Non-Current Assets
Operating Lease Right-of-Use Assets in Other Assets
Edwards Lifesciences Operating Lease Right-of-Use Assets in Other Assets decreased by 3.3% to $99.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.5%, from $96.90M to $99.30M. Over 5 years (FY 2020 to FY 2025), Operating Lease Right-of-Use Assets in Other Assets shows relatively stable performance with a 1.7% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
First reportedQ1 2019
Last reportedQ1 2026May 6, 2026
Metric ID:
operating_lease_rou_assets_in_otherHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $84.60M | $84.80M | $92.10M | $90.10M | $84.20M | $87.70M | $92.30M | $88.50M | $84.90M | $90.90M | $84.40M | $98.40M | $92.80M | $104.40M | $98.20M | $96.90M | $99.00M | $96.50M | $102.70M | $99.30M |
| QoQ Change | — | +0.2% | +8.6% | -2.2% | -6.5% | +4.2% | +5.2% | -4.1% | -4.1% | +7.1% | -7.2% | +16.6% | -5.7% | +12.5% | -5.9% | -1.3% | +2.2% | -2.5% | +6.4% | -3.3% |
| YoY Change | — | — | — | — | -0.5% | +3.4% | +0.2% | -1.8% | +0.8% | +3.6% | -8.6% | +11.2% | +9.3% | +14.9% | +16.4% | -1.5% | +6.7% | -7.6% | +4.6% | +2.5% |
Range$84.20M – $104.40M
CAGR+3.4%
Avg YoY Growth+3.4%
Median YoY Growth+2.9%
Operating Lease Right-of-Use Assets in Other Assets at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's operating lease right-of-use assets in other assets?
- Edwards Lifesciences (EW) reported operating lease right-of-use assets in other assets of $99.30M in Q1 2026.
- How has Edwards Lifesciences's operating lease right-of-use assets in other assets changed year-over-year?
- Edwards Lifesciences's operating lease right-of-use assets in other assets increased by 2.5% year-over-year, from $96.90M to $99.30M.
- What is the long-term trend for Edwards Lifesciences's operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), Edwards Lifesciences's operating lease right-of-use assets in other assets has grown at a 1.7% compound annual growth rate (CAGR), from $94.20M to $102.70M.